ARTICLE | Company News
Cellular Biomedicine, GE deal
April 14, 2017 4:34 PM UTC
Cellular Biomedicine and the GE Healthcare Life Science China unit of General Electric Co. partnered to jointly develop automated systems for manufacturing chimeric antigen receptor T cell and stem cell therapies. The partners said the system will be designed to minimize variability in cell production, improve throughput and reduce costs. The partners will establish a joint laboratory in Shanghai to develop the system...